# 2026-09284: Join FDA's Animal Generic Drug Fee Renewal Stakeholder Chats

2026-09284, Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intent To Participate, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-05-11, effective 2026-06-01 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-09284
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-09284
- Title: Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intent To Participate
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 25577
- Published: 2026-05-11
- Effective: 2026-06-01
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Join FDA's Animal Generic Drug Fee Renewal Stakeholder Chats

## Summary

The FDA is gearing up to renew the Animal Generic Drug User Fee Act (AGDUFA) before it expires in September 2028. They’re inviting vets, scientists, and animal drug makers to join regular meetings starting June 2026 to help shape the next phase. This means ongoing teamwork and funding to keep affordable animal medicines coming!

## Abstract

The Food and Drug Administration (FDA, the Agency, or we) is issuing this notice to request that public stakeholders notify FDA of their intent to participate in periodic consultation meetings on reauthorization of the Animal Generic Drug User Fee Act (AGDUFA). The statutory authority for AGDUFA expires September 30, 2028. The Federal Food, Drug, and Cosmetic Act (FD&C Act) requires that FDA consult with a range of stakeholders--including patient and consumer advocacy groups, veterinary professionals, and scientific and academic experts-- in developing recommendations for the next AGDUFA program and hold discussions with these stakeholders at least once every 4 months during FDA's negotiations with the regulated industry. The purpose of this request for notification is to ensure consistent stakeholder representation at the consultation meetings.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-09284 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/11/2026-09284/animal-generic-drug-user-fee-act-stakeholder-consultation-meetings-on-the-animal-generic-drug-user)
- [2026-09284 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-11/pdf/2026-09284.pdf)

## Related
- [Previous: 2026-09283, Animal Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Drug…](https://policyrisk.com/federal-register/2026-09283)
- [Next: 2026-09285, Agency Information Collection Request; 60-Day Public Comment Request](https://policyrisk.com/federal-register/2026-09285)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-09284 (as of 2026-06-08).
